Literature DB >> 9524964

Blockade of N-methyl-D-aspartate receptor prevents hypoxic neuronal death and cytokine release.

S Di Loreto1, M Balestrino, P Pellegrini, A M Berghella, T Del Beato, F Di Marco, D Adorno.   

Abstract

Neuronal mortality, interleukin-1 beta (IL1 beta) and tumor necrosis factor-alpha (TNF alpha) release were measured in hypoxic hippocampal neuronal cultures. Release of IL 1 beta and TNF alpha was already observed in normoxic cultures, but after hypoxia it was increased approximately 2-fold. Pretreatment with 2-amino-5-phosphonovaleric acid (APV), the N-methyl-D-aspartate (NMDA) receptor antagonist, not only decreased neuronal mortality as expected, but also dramatically lowered cytokine release. However, there was no relationship between the neuronal mortality and the release of each cytokine both in untreated hypoxic cultures and in APV-pretreated ones. We conclude that IL 1 beta and TNF alpha release in hypoxia are dependent on the activation of the NMDA receptor, but that this is not the main mechanism of hypoxia damage in in vitro neuronal cultures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9524964     DOI: 10.1159/000097338

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  3 in total

Review 1.  A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.

Authors:  Djo Hasan; Atsuko Shono; Coenraad K van Kalken; Peter J van der Spek; Eric P Krenning; Toru Kotani
Journal:  Purinergic Signal       Date:  2021-11-10       Impact factor: 3.765

2.  Blockade of NMDA receptor subtype NR2B prevents seizures but not apoptosis of dentate gyrus neurons in bacterial meningitis in infant rats.

Authors:  Anna Kolarova; Ralph Ringer; Martin G Täuber; Stephen L Leib
Journal:  BMC Neurosci       Date:  2003-09-16       Impact factor: 3.288

3.  Temporal dynamics of glyoxalase 1 in secondary neuronal injury.

Authors:  Philipp Pieroh; Marco Koch; Daniel-Christoph Wagner; Johannes Boltze; Angela Ehrlich; Chalid Ghadban; Constance Hobusch; Gerd Birkenmeier; Faramarz Dehghani
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.